High Systolic Blood Pressure Is Associated With Val/Val Genotype in the Catechol-O-Methyltransferase Gene. The Nord-Trøndelag Health Study (HUNT)

American Journal of Hypertension

Volumn 20, Issue 1, 2007, Pages 21-26

  Hagen, Knut ^a,c   Pettersen, Elin ^a   Stovner, Lars Jacob ^a,c   Skorpen, Frank ^a   Holmen, Jostein ^b   Zwart, John Anker ^a,c,d  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c Norwegian National Headache Centre   (Norway)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Blood pressure; epidemiology; genetics; Norway; polymorphism

Indexed keywords

ANTIHYPERTENSIVE AGENT; CATECHOL METHYLTRANSFERASE; VALINE;

ADULT; AMINO ACID SUBSTITUTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; BLOOD PRESSURE; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NORWAY; POLYMORPHISM, SINGLE NUCLEOTIDE; SYSTOLE; VALINE;

EID: 33845746879     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2006.05.023     Document Type: Article

References (24)

1. Ward R. Familial aggregation and genetic epidemiology of blood pressure. In: Laragh J.H., and Brenner B.P. (Eds). Hypertension: Pathophysiology, Diagnosis and Management Vol. 1 (1990), Raven Press, New York 81-100
2. Naber C.K., and Siffert W. Genetics of human arterial hypertension. Minerva Med 95 (2004) 347-356
3. Kuchel O: Genetic determinants of dopaminergic activity: potential role in blood pressure regulation. Hypertens Res 18 Suppl 1 (1995) S1-S10
4. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Melén K., Julkunen I., and Taskinen J. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34 (1995) 4202-4210
5. Helkamaa T., Männistö P.T., Rauhala P., Cheng Z.J., Finchenberg P., Houtari M., Gogos J.A., Karayiorgou M., and Marvaala E.M.A. Resistance to salt-induced hypertension in catechol-O-methyltransferase-gene-disrupted mice. J Hypertens 21 (2003) 2365-2374
6. Tsunoda M., Tenhunen J., Tilgmann C., Arai H., and Imai K. Reduced membrane-bound catechol-O-methyltransferase in liver of spontaneously hypertensive rats. Hypertens Res 26 (2003) 923-927
7. Masuda M., Tsunoda M., and Imai K. Low catechol-O-methyltransferase activity in the brain and blood pressure regulation. Biol Pharm Bull 29 (2006) 202-205
8. Sun B., Zhang W.Y., and Zhao Y.H. Association between catechol-methyltransferase gene polymorphism and pregnancy-induced hypertension. Zhonghua Fu Chan Za Zhi 39 (2004) 21-23
9. 158met Genotype affects μ-opioid neurotransmitter responses to a pain stressor. Science 299 (2003) 1240-1243
10. Hagen K., Stovner L.J., Vatten L., Holmen J., Zwart J.A., and Bovim G. Blood pressure and risk of headache: a prospective study of 22,685 adults in Norway. J Neurol Neurosurg Psychiatry 72 (2002) 463-466
11. Hagen K., Zwart J.A., Holmen J., Svebak S., Bovim G., and Stovner L.J. Does hypertension protect against chronic musculoskeletal complaints? The Nord-Trøndelag Health Study (HUNT). Arch Intern Med 165 (2005) 916-922
12. Holmen J., Midthjell K., Krüger Ø., Langhammer A., Holmen T.L., Bratberg G.H., Vatten L., and Lund-Larsen P.G. The Nord-Trøndelag Health Study 1995-97 (HUNT 2): objectives, contents, methods and participation. Nor J Epidemiol 13 (2003) 19-32
13. Langhammer A., Johnsen R., Holmen J., Gulsvik A., Bjermer L., and The Nord-Trøndelag Health Study (HUNT). Cigarette smoking gives more respiratory symptoms among women than among men. J Epidemiol Community Health 54 (2000) 917-922
14. Wittwer C.T., Ririe K.M., Andrew R.V., David D.A., Gundry R.A., and Balis U.J. The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 22 (1997) 176-181
15. Koivukoski L., Fisher S.A., Kanninen T., Lewis C.M., von Wowern F., Hunt S., Kardia S.L.R., Levy D., Perola M., Rankinen T., Rao D.C., Rice T., Thiel B.A., and Melander O. Meta-analysis of genome-wide scans for hypertension and blood pressure in Caucasians shows evidence of susceptibility regions on chromosomes 2 and 3. Hum Mol Gen 13 (2004) 2325-2332
16. Rice T., Rankinen T., Province M.A., Chagnon Y.C., Pérusse L., Borecki I.B., Bouchard C., and Rao D.C. Genome-wide linkage analysis of systolic and diastolic blood pressure: the Québec Family Study. Circulation 102 (2000) 1956-1963
17. Perola M., Kainulainen P.M., Pajukanta P., Terwillinger J.D., Hiekkalinna T., Ellonen P., Kaprio J., Koskenvuo M., Kontula K., and Peltonen L. Genome-wide scan of predisposing loci for increased diastolic blood pressure in Finnish siblings. J Hypertens 18 (2000) 1579-1585
18. Rankinen T., An P., Rice T., Sun G., Chagnon Y.C., Gagnon J., Leon A.S., Skinner J.S., Wilmore J.H., Rao D.C., and Bouchard C. Genome scan for exercise blood pressure in the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Hypertens 38 (2001) 30-37
19. Illi A., Sundberg S., Koulu M., Scheinin M., Heinävaara S., and Gordin A. COMT inhibition by high-dose entacapone does not affect hemodynamics but changes catecholamone metabolism in healthy volunteers at rest and during exercise. Int J Clin Pharmachol Ther 32 (1994) 582-588
20. Lyytinen J., Sovijary A., Kaakkola S., Gordin A., and Teräväinen H. The effect of catechol-O-methyltransferase inhibition with entacapone on cardiovascular autonomic responses in l-dopa-treated patients with Parkinson's disease. Clin Neuropharmacol 24 (2001) 50-57
21. Jose P.A., Eisner G.M., and Felder R.A. Regulation of blood pressure by dopamine receptors. Nephron Physiol 95 (2003) 19-27
22. Eriksson A.L., Skrtic S., Niklason A., Hultén L.M., Wiklund O., Hedner T., and Ohlsson C. Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population. Eur Heart J 25 (2004) 386-391
23. Diatchenko L., Slade G.D., Nackley A.G., Bhalang K., Sigurdsson A., Belfer I., Oldman D., Xu K., Shabalina S.A., Shagin D., Max M.B., Marakov S.S., and Maixner W. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Gen 14 (2005) 135-143
24. Sterne J.A., and Smith G.D. Sifting the evidence-what's wrong with significance tests?. Br Med J 322 (2001) 226-231